Has Timothy Davis received payments from drug or device companies?

Yes. Drug and device makers reported $165,916 in general payments to Timothy Davis across 990 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Timothy Davis did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Timothy Davis come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Timothy Davis

Pain Medicine · Santa Monica, CANPI 1770515603

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (54.8%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by Boston Scientific at 33.0% of the total. Reporting peaked in 2019 at $68,874 and has fallen 91.0% since, to $6,168 in 2025. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$165,916in general payments, 2019–2025

Across 990 payments — averaging $167.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$55K
Vertiflex, Inc.$51K
Abbott$20K
Biotronik NRO, Inc.$18K
Surgalign Spine Technologies, Inc.$9K
Medtronic$6K
plus $8K from 40 others

$216,790in research payments, 2019–2025

Across 69 payments — averaging $3141.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Mesoblast, Inc.$119K
Seikagaku Corporation$59K
Abbott$13K
Si-bone, Inc.$12K
Pacira Pharmaceuticals Incorporated$7K
Boston Scientific$4K
plus $2K from 2 others

What the payments were for

Consulting fees$43,23826%
Speaking & faculty fees$91,00455%
Travel & lodging$8,9685%
Food & beverage$22,67314%
Education$330%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	92	$54,812
Vertiflex, Inc.	52	$50,932
Abbott	195	$19,928
Biotronik NRO, Inc.	128	$17,824
Surgalign Spine Technologies, Inc.	3	$8,515
Medtronic(2 entities)	306	$6,035
Nevro Corp.	56	$2,423
Si-bone, Inc.	26	$1,778
IBSA Pharma Inc.	27	$448
Painteq LLC	7	$423
Nalu Medical, Inc.	13	$356
Globus Medical	7	$342
Mesoblast, Inc.	1	$178
Arbor Pharmaceuticals, Inc.	9	$175
Kerecis Limited	1	$150
Collegium Pharmaceutical, Inc.	8	$122
Spinal Simplicity, LLC	3	$121
Vertex	3	$113
Curonix LLC	4	$101
Bioventus LLC	3	$100
7d Surgical Inc.	2	$92
Relievant Medsystems, Inc.	2	$72
Biodelivery Sciences International, Inc.	4	$67
Saluda Medical Americas, Inc.	1	$65
Azurity Pharmaceuticals, Inc.	4	$64
Virtus Pharmaceuticals LLC	3	$61
Valinor Pharma, LLC	3	$60
Merz Pharmaceuticals, LLC	2	$57
Radius Health, Inc.	3	$55
Zimmer Biomet	2	$50
Flowonix Medical Incorporated	1	$47
Amgen	2	$44
Stryker	2	$44
Redhill Biopharma Inc.	2	$41
Neuronetics, Inc.	1	$33
Daiichi Sankyo Inc.	2	$23
DJO, LLC	1	$23
Johnson & Johnson	1	$20
Lilly USA, LLC	1	$20
Ferring Pharmaceuticals Inc.	1	$19
Hydrocision, Inc.	1	$18
Kowa Pharmaceuticals America, Inc.	1	$17
Stratus Medical, LLC	1	$15
Sentynl Therapeutics, Inc.	1	$12
Scilex Pharmaceuticals Inc.	1	$12
SPR Therapeutics, Inc	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Superion ISS$49,774
SUPERION$35,361
VERIFLEX$16,250
Proclaim Family of SCS IPGs$15,000
Prospera$14,982
coflex$8,470
GENERAL PAIN MANAGEMENT$1,111
Omnia$1,015
IFUSE IMPLANT SYSTEM$835
BIOTRONIK$638
Kerecis SurgiClose$599
Axium INS DRG IPG$396
Lamitrode SCS Leads$370
Axium Sheath Braided DRG$318
INTELLIS ADAPTIVESTIM$257
PROCLAIM$182
Senza Spinal Cord Stimulation System$180
Ryoncil$178
GENERAL - THERAPIES$166
Kerecis GraftGuide$150

How this compares

$165,916 in reported general payments places this provider in the 95th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	27	$616
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	29	$471
Gabapentin	34	$413
Topiramate	22	$235
Tramadol Hcl	12	$102
Cephalexin	17	$89

Paid to pharmacies, not to this prescriber.

Other pain medicine in Santa Monica

Gerald SacksSanta Monica$389K
Javid GhandehariSanta Monica$188K
Jason PopeSanta Rosa$2.1M
Ramana NaiduLarkspur$1.4M
Foead GeulaStudio City$1.3M
Krishnan ChakravarthyTemecula$1.3M
Kasra AmirdelfanWalnut Creek$783K
Eric GrigsbyNapa$499K
Jacqueline WeisbeinNapa$494K
Samir ShethRoseville$356K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →